The Medicines Company is a biopharmaceutical company whose purpose is to halt the deadly progression of atherosclerosis and the cardiovascular risk created by high levels of LDL-C, or bad cholesterol. The team is focused on transformational solutions that address the daily challenges which patients, physicians and payers confront in cardiovascular care. The company is headquartered in Parsippany, New Jersey.